A61K 45 - Medicinal preparations containing active ingredients not provided for in groups

Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
10/1998
10/21/1998	EP0871458A1 Method of decreasing radiation or radio-mimetic chemotherapy for hematopoietic pluripotent cell engraftment
10/21/1998	EP0871446A1 Use of polyamine site antagonist for the manufacture of a medicament for the treatment of ischemic disorders of the eye
10/21/1998	EP0871445A1 Composition for treating pain
10/21/1998	EP0871440A1 Treatment of negative and cognitive symptoms of schizophrenia with glycine uptake antagonists
10/21/1998	EP0871437A1 Use of boswellic acid for treating brain tumours
10/21/1998	EP0871436A1 USE OF Stat 6 SH2 DOMAIN SPECIFIC COMPOUNDS TO TREAT ALLERGIC REACTIONS
10/21/1998	EP0871432A2 Biological agent compositions
10/21/1998	EP0871376A1 Enhancement of vascular function by modulation of endogenous nitric oxide production or activity
10/21/1998	EP0651740B1 Amino acid linked nitrogen mustard derivatives and their use as prodrugs in the treatment of tumours
10/21/1998	CN1196734A Anti-inflammatory agent
10/20/1998	US5824781 Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules
10/20/1998	US5824776 Cell-targeted lytic pore-forming agents
10/20/1998	US5824775 Human netrin-1
10/20/1998	US5824696 Medicaments
10/20/1998	US5824693 Method for treatment for pulmonary disease
10/20/1998	US5824685 Vision defects and gene expression
10/20/1998	US5824669 Treating asthma
10/20/1998	US5824665 Reduction of hair growth
10/20/1998	US5824658 Topical composition containing hyaluronic acid and NSAIDS
10/20/1998	US5824655 Anti-transforming growth factor-β gene therapy
10/20/1998	US5824500 Nucleic acid encoding novel human KDEL receptor
10/20/1998	US5824304 Peripheralization of hematopoietic stem cells
10/17/1998	CA2243983A1 Sublingual drug formulations having combined rapid onset of action and long lasting therapeutic effect
10/15/1998	WO1998045711A2 Assay for ligands to tyrosine kinase receptors
10/15/1998	WO1998045477A2 Methods for assessing cardiovascular status and compositions for use thereof
10/15/1998	WO1998045439A1 Human tumor-associated membrane protein
10/15/1998	WO1998045434A1 Novel human delta3 compositions and therapeutic and diagnostic uses therefor
10/15/1998	WO1998045432A1 Renal nuclear matrix proteins, polynucleotide sequences encoding them, and their use
10/15/1998	WO1998045427A2 Insulin-like growth factor agonist peptides
10/15/1998	WO1998045270A1 Pharmacological agents
10/15/1998	WO1998045268A1 Nicotinamide derivatives
10/15/1998	WO1998045256A1 Hydroxamic acid derivatives
10/15/1998	WO1998044953A1 Methods for the modulation of the growth of collateral arteries and/or other arteries from preexisting arteriolar connections
10/15/1998	WO1998044940A1 Use of lactoferin in the treatment of allergen induced disorders
10/15/1998	WO1998044934A1 Cytokine and cisplatin-based gene therapy of carcinomas
10/15/1998	WO1998044919A1 Use of aminothiolester derivatives in pharmaceutics
10/15/1998	WO1998044913A2 Compositions containing mkc-442 in combination with other antiviral agents
10/15/1998	WO1998044893A2 Method and formulation for treating vascular disease
10/15/1998	WO1998044797A1 A method of treating cancer
10/15/1998	WO1998035693A3 Detection and modulation of the iaps and naip for the diagnosis and treatment of proliferative disease
10/15/1998	WO1998024887A3 Parasitic nematode transglutaminase proteins, nucleic acid molecules, and uses thereof
10/15/1998	WO1998022500A3 Modulation of interactions between myosin and integrins
10/15/1998	WO1998017810A3 Multi-functional chimeric hematopoietic receptor agonists
10/15/1998	DE19715504A1 PMMA-Membranen mit Polyethylenglykol-gekoppelten Wirksubstanzen PMMA membranes with polyethylene glycol-coupled active substances
10/15/1998	DE19714875A1 First aid kit for prophylaxis of blood-borne infections e.g. HIV or hepatitis in e.g. police and medical or laboratory staff
10/15/1998	CA2287778A1 Renal nuclear matrix proteins, polynucleotide sequences encoding them, and their use
10/15/1998	CA2286390A1 Human tumor-associated membrane protein
10/15/1998	CA2286264A1 Insulin-like growth factor agonist peptides
10/15/1998	CA2286239A1 A method of treating cancer
10/15/1998	CA2285960A1 Use of lactoferin in the treatment of allergen induced disorders
10/15/1998	CA2285933A1 Assay for ligands to tyrosine kinase receptors
10/15/1998	CA2285906A1 Hydroxamic acid derivatives
10/15/1998	CA2285671A1 Methods for assessing cardiovascular status and compositions for use thereof
10/15/1998	CA2285577A1 Compositions containing mkc-442 in combination with other antiviral agents
10/15/1998	CA2285192A1 Pharmacological agents
10/15/1998	CA2285020A1 Novel human delta3 compositions and therapeutic and diagnostic uses therefor
10/15/1998	CA2284922A1 Methods for the modulation of the growth of collateral arteries and/or other arteries from preexisting arteriolar connections
10/14/1998	EP0870825A1 Human protein kinases hYAK3
10/14/1998	EP0870506A1 Compositions comprising a cryptophycin compound in combination with a synchronizing or activating agent for treating cancer
10/14/1998	EP0870041A2 KVLQT1 - A LONG QT SYNDROME GENE WHICH ENCODES KVLQT1 WHICH COASSEMBLES WITH minK TO FORM CARDIAC I Ks? POTASSIUM CHANNELS
10/14/1998	EP0870038A1 INTERLEUKIN-1$g(b) CONVERTING ENZYME LIKE CYSTEINE PROTEASE
10/14/1998	EP0870035A2 A novel protein kinase required for ras signal transduction
10/14/1998	EP0870034A1 Novel nagpu
10/14/1998	EP0870033A1 Integrin-linked kinase, its inhibitors and methods of medical treatment using these inhibitors, gene therapy and pseudo-substrate inhibitors
10/14/1998	EP0870028A1 Nucleic acids encoding interferon gamma inducing factor-2
10/14/1998	EP0869975A1 Assay for and uses of peptide hormone receptor ligands
10/14/1998	EP0869972A1 Chemokine from niddm pancreas
10/14/1998	EP0869971A1 Two component signal transducing system protein from staphylococcus aureus
10/14/1998	EP0869970A1 Endothelial cell proliferation inhibitor and method of use
10/14/1998	EP0869818A1 Cytotoxic agents
10/14/1998	EP0869807A2 Use of a medicament and use of mixture of substances to produce a medicament
10/14/1998	EP0869804A1 Supplemented and unsupplemented tissue sealants, methods of their production and use
10/14/1998	EP0869802A1 Vertebrate deltex proteins, nucleic acids, and antibodies, and related methods and compositions
10/14/1998	EP0869789A1 Antiviral agent
10/14/1998	EP0869782A2 METHODS OF TREATMENT WITH COMPOUNDS HAVING RAR $g(a)? RECEPTOR SPECIFIC OR SELECTIVE ACTIVITY
10/14/1998	EP0869773A1 Archaeosomes, archaeosomes containing coenzyme q 10?, and other types of liposomes containing coenzyme q 10? as adjuvants and as delivery vehicles
10/14/1998	EP0806947A4 Formulations and methods for reducing skin irritation
10/14/1998	EP0673366B1 5-methanesulfonamido-1-indanones as an inhibitor of cyclooxygenase-2
10/14/1998	CN1195986A Paroxetine controlled release compositions
10/14/1998	CN1195982A Fgfr 3 as marker for mesenchymal skelftal progenitor cells
10/14/1998	CN1195524A Pharmaceutical formulation
10/13/1998	US5821260 Administering compounds which block expression of vascular cell adhesion molecule
10/13/1998	US5821241 Inhibit binding of fibrinogen to blood platelets, inhibit aggregation of blood platelets, prevent or treat thrombus or embolus formation
10/13/1998	US5821232 Administering renin inhibitor and angiotensin ii antagonist to treat hypertension or congestive heart failure
10/13/1998	US5821123 Modified antibody variable domains
10/13/1998	US5821122 Isolated nucleic acid molecules, peptides which form complexes with MHC molecule HLA-A2 and uses thereof
10/13/1998	US5821056 Polynucleotide; expression vector; binding of antibody to a growth differentiation factor-9 polypeptide indicates the presence of an oocyte
10/13/1998	US5820587 Method and kit for preventing erectile dysfunction
10/13/1998	US5820583 Surgical irrigation solution and method for inhibition of pain and inflammation
10/13/1998	CA2132578C Method of tumor treatment
10/08/1998	WO1998044128A1 Novel human serine carboxypeptidase
10/08/1998	WO1998044107A1 Diagnosis and prognosis of glaucoma
10/08/1998	WO1998044021A1 Biodegradable terephthalate polyester-poly(phosphate) polymers, compositions, articles, and methods for making and using the same
10/08/1998	WO1998043667A1 Methods and compositions for treating inflammatory bowel disease
10/08/1998	WO1998043666A1 Antioxidant protein 2, gene and methods of use therefor
10/08/1998	WO1998043661A1 Use of substances having oxytocin activity for preparation of medicaments for wound healing
10/08/1998	WO1998043660A1 Use of substances having oxytocin activity for preparation of medicaments for the treatment of affective pain syndromes
10/08/1998	WO1998043646A1 New therapeutic combinations of mirtazapine and antipsychotic agents, for the treatment or prophylaxis of psychotic disorders
10/08/1998	WO1998043622A1 Use of inhibitors of undecaprenol kinase to inhibit cell wall biosynthesis
10/08/1998	WO1998043612A1 Use of sodium channel blocker in the manufacture of a medicament for preventing optic nerve degeneration associated with glaucoma

1 ... 1041 1042 1043 1044 1045 1046 1047 1048 1049 1050 1051 1052 1053 1054 1055 1056 1057 1058 1059 1060 1061 ... 1151